SCHEMBL6132067

SCHEMBL6132067

Nc1n[nH]c(-c2ccc(F)cc2)c1-c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.80
NPSR1 Q6W5P4 1/20 0.80
MAPK14 Q16539 2/20 0.74
RPS6KA3 P51812 2/20 0.71
AKT2 P31751 1/20 0.53
KMT2A Q03164 1/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
ILK Q13418 4/20 0.50
CYP3A4 P08684 1/20 0.50
KDM4E B2RXH2 1/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
GAA P10253 1/20 0.46
HPGD P15428 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HSD17B10 Q99714 1/20 0.46
DAPK3 O43293 1/20 0.45
PRKD3 O94806 1/20 0.45
MAP4K4 O95819 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6132080 1.00 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL5820038 0.89 MAPK1 (1.00) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL6076585 0.85 MAPK14 (1.00) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6179977 0.85 MAPK14 (1.00) MAPK1NPSR1MAPK14RPS6KA3ILK
SCHEMBL6132021 0.84 MAPK1 (0.70) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL6132090 0.84 MAPK1 (0.70) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL6132022 0.83 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL6132076 0.83 MAPK1 (0.80) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL6132051 0.81 MAPK1 (0.83) MAPK1NPSR1MAPK14RPS6KA3AKT2
SCHEMBL9514098 0.80 MAPK14 (0.61) MAPK1NPSR1MAPK14RPS6KA3AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1435957-A4 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMA (US) 2005-04-13 EP disclosed
EP-1435957-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3BETA PROTEIN AND PROTEIN COMPLEXES Vertex Pharmaceuticals Incorporated (US) 2004-07-14 EP disclosed
WO-2002088078-A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES VERTEX PHARMACEUTICALS INCORPORATED (US) 2002-11-07 WO disclosed